Some advances have already changed the treatment landscape for wet AMD, while the development of therapies for advanced dry AMD has historically been more difficult.
The National Eye Institute continues to support research aimed at understanding the biological mechanisms behind AMD and developing better treatments.
For patients and families, these developments offer hope — but they should not be confused with a guaranteed cure.
AMD remains a complex disease, and treatment depends on its specific form and stage.
Dench's experience demonstrates why scientific progress matters. A diagnosis that once offered very limited options can now be managed much more effectively in many cases, particularly when detected early.
But for people who have already experienced extensive retinal damage, preventing additional loss and helping them adapt to low vision may be just as important as attempting to restore sight.
A life reshaped, not erased
Judi Dench's latest comments are painful because they describe the loss of something most people barely think about until it begins to disappear.
Seeing a face.
Reading a page.
Watching television.
Walking somewhere alone.
Looking at the people you love.
For Dench, these ordinary experiences have become increasingly difficult.
Yet her story also shows that a meaningful life does not end when one ability is lost.
She has adapted her relationship with scripts. She has relied on other people's voices. She has drawn on an extraordinary memory. She has continued to engage with Shakespeare. And she has used humor to discuss an experience that could understandably be overwhelming.
Her description of the condition as “a crusher” reveals the emotional reality of severe sight loss. But the fact that she continues to work, speak, teach and participate in cultural life reveals another side of the story.
It is possible to grieve what has been lost while continuing to find meaning in what remains.
At 91, Dench is confronting a world that looks very different from the one she knew at the height of her acting career.
But the words she has carried for decades are still there.
The Shakespeare is still there.
The stories are still there.
And, in a career defined by the ability to make words come alive, perhaps that is the most important thing of all.
Understanding the medical reality
Dench's experience should not be used to suggest that everyone with AMD will eventually experience the same degree of vision loss. AMD progresses differently from person to person, and some people retain useful vision for many years.
Nor should her story be interpreted as evidence that AMD inevitably causes complete blindness.
According to the National Eye Institute, advanced AMD can severely damage central vision while leaving some peripheral vision intact. Treatment options vary according to whether the disease is wet or dry and according to its stage.
For anyone experiencing new or worsening central vision changes, distorted straight lines, difficulty recognizing faces or unexplained changes in reading ability, professional eye care is important.
Early detection can make a significant difference in management.
And for people already living with advanced vision loss, low-vision rehabilitation and assistive technologies can provide practical ways to remain active and independent.
Judi Dench's story is therefore both deeply personal and broadly relevant.
It is the story of an extraordinary actress confronting a profound physical limitation — but it is also a reminder that losing part of one's vision does not necessarily mean losing one's voice, one's memories, one's relationships or one's capacity to contribute.
After more than a decade of living with macular degeneration, Dench knows better than most that the world can change dramatically without warning.
Her challenge now is not simply to see the world as she once did.
It is to continue finding ways to experience, interpret and share it.
And, despite everything her eyesight has taken away, she is still doing exactly that.